Deal Watch: Jazz Breaks Into Immuno-Oncology Via Licensing Pact With Werewolf
Executive Summary
AstraZeneca licenses bispecific cancer antibody candidate from Harbour Biomed. Regeneron seeks new approach to gene therapy delivery in deal with ViGeneron.